Molecular imaging of bacterial infections in vivo: The discrimination between infection and inflammation

Informatics

Volumn 1, Issue 1, 2014, Pages 72-99

  Eggleston, Heather ^a   Panizzi, Peter ^a  

^a AUBURN UNIVERSITY   (United States)

Author keywords

Endocarditis; Infection; Inflammation; Molecular imaging; Staphylococcus aureus

Indexed keywords

EID: 84925738334     PISSN: None     EISSN: 22279709     Source Type: Journal    
DOI: 10.3390/informatics1010072     Document Type: Review

References (176)

1. Gemmel, F.; Dumarey, N.; Welling, M. Future diagnostic agents. Semin. Nucl. Med. 2009, 39, 11–26.
2. Goldsmith, S.J.; Vallabhajosula, S. Clinically proven radiopharmaceuticals for infection imaging: Mechanisms and applications. Semin. Nucl. Med. 2009, 39, 2–10.
3. Palestro, C.J.; Brown, M.L.; Forstrom, L.A.; Greenspan, B.S.; McAfee, J.G.; Royal, H.D.; Schauwecker, D.S.; Seabold, J.E.; Signore, A. Society of Nuclear Medicine Procedure Guideline for 99mTc-Exametazime (HMPAO)-Labeled Leukocyte Scintigraphy for Suspected Infection/Inflammation; The Society of Nuclear Medicine: Reston, VA, USA, 2004.
4. Palestro, C.J.; Brown, M.L.; Forstrom, L.A.; McAfee, J.G.; Royal, H.D.; Schauwecker, D.S.; Seabold, J.E.; Signore, A. Society of Nuclear Medicine Procedure Guideline for 111In-Leukocyte Scintigraphy for Suspected Infection/Inflammation; The Society of Nuclear Medicine: Reston, VA, USA, 2004.
5. Signore, A. About inflammation and infection. EJNMMI Res. 2013, 3, 8, doi:10.1186/2191-219X-3-8.
6. Nahrendorf, M.; Jaffer, F.A.; Kelly, K.A.; Sosnovik, D.E.; Aikawa, E.; Libby, P.; Weissleder, R. Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis. Circulation 2006, 114, 1504–1511.
7. Kelly, K.A.; Nahrendorf, M.; Yu, A.M.; Reynolds, F.; Weissleder, R. In vivo phage display selection yields atherosclerotic plaque targeted peptides for imaging. Mol. Imaging Biol. 2006, 8, 201–207.
8. Kelly, K.A.; Allport, J.R.; Tsourkas, A.; Shinde-Patil, V.R.; Josephson, L.; Weissleder, R. Detection of vascular adhesion molecule-1 expression using a novel multimodal nanoparticle. Circ. Res. 2005, 96, 327–336.
9. Wong, R.; Chen, X.; Wang, Y.; Hu, X.; Jin, M.M. Visualizing and quantifying acute inflammation using ICAM-1 specific nanoparticles and MRI quantitative susceptibility mapping. Ann. Biomed. Eng. 2012, 40, 1328–1338.
10. Choi, K.S.; Kim, S.H.; Cai, Q.Y.; Kim, S.Y.; Kim, H.O.; Lee, H.J.; Kim, E.A.; Yoon, S.E.; Yun, K.J.; Yoon, K.H. Inflammation-specific T1 imaging using anti-intercellular adhesion molecule 1 antibody-conjugated gadolinium diethylenetriaminepentaacetic acid. Mol. Imaging 2007, 6, 75–84.
11. Hariri, G.; Zhang, Y.; Fu, A.; Han, Z.; Brechbiel, M.; Tantawy, M.N.; Peterson, T.E.; Mernaugh, R.; Hallahan, D. Radiation-guided P-selectin antibody targeted to lung cancer. Ann. Biomed. Eng. 2008, 36, 821–830.
12. Jacobin-Valat, M.J.; Deramchia, K.; Mornet, S.; Hagemeyer, C.E.; Bonetto, S.; Robert, R.; Biran, M.; Massot, P.; Miraux, S.; Sanchez, S.; et al. MRI of inducible P-selectin expression in human activated platelets involved in the early stages of atherosclerosis. NMR Biomed. 2011, 24, 413–424.
13. Ji, S.; Fang, W.; Zhu, M.; Bai, X.; Wang, C.; Ruan, C. Detection of pulmonary embolism with 99mTc-labeled F(ab)2 fragment of anti-P-selectin monoclonal antibody in dogs. Tohoku J. Exp. Med. 2011, 223, 9–15.
14. McAteer, M.A.; Schneider, J.E.; Ali, Z.A.; Warrick, N.; Bursill, C.A.; von zur Muhlen, C.; Greaves, D.R.; Neubauer, S.; Channon, K.M.; Choudhury, R.P. Magnetic resonance imaging of endothelial adhesion molecules in mouse atherosclerosis using dual-targeted microparticles of iron oxide. Arterioscler. Thrombosis Vasc. Biol. 2008, 28, 77–83.
15. Rouzet, F.; Bachelet-Violette, L.; Alsac, J.M.; Suzuki, M.; Meulemans, A.; Louedec, L.; Petiet, A.; Jandrot-Perrus, M.; Chaubet, F.; Michel, J.B.; et al. Radiolabeled fucoidan as a p-selectin targeting agent for in vivo imaging of platelet-rich thrombus and endothelial activation. J. Nucl. Med. 2011, 52, 1433–1440.
16. Jamar, F.; Chapman, P.T.; Harrison, A.A.; Binns, R.M.; Haskard, D.O.; Peters, A.M. Inflammatory arthritis: Imaging of endothelial cell activation with an indium-111-labeled F(ab')2 fragment of anti-E-selectin monoclonal antibody. Radiology 1995, 194, 843–850.
17. Jamar, F.; Chapman, P.T.; Manicourt, D.H.; Glass, D.M.; Haskard, D.O.; Peters, A.M. A comparison between 111In-anti-E-selectin mAb and 99Tcm-labelled human non-specific immunoglobulin in radionuclide imaging of rheumatoid arthritis. Br. J. Radiol. 1997, 70, 473–481.
18. Jamar, F.; Houssiau, F.A.; Devogelaer, J.P.; Chapman, P.T.; Haskard, D.O.; Beaujean, V.; Beckers, C.; Manicourt, D.H.; Peters, A.M. Scintigraphy using a technetium 99m-labelled anti-E-selectin Fab fragment in rheumatoid arthritis. Rheumatology 2002, 41, 53–61.
19. Sibson, N.R.; Blamire, A.M.; Bernades-Silva, M.; Laurent, S.; Boutry, S.; Muller, R.N.; Styles, P.; Anthony, D.C. MRI detection of early endothelial activation in brain inflammation. Magn. Reson. Med. 2004, 51, 248–252.
20. Gross, S.; Gammon, S.T.; Moss, B.L.; Rauch, D.; Harding, J.; Heinecke, J.W.; Ratner, L.; Piwnica-Worms, D. Bioluminescence imaging of myeloperoxidase activity in vivo. Nat. Med. 2009, 15, 455–461.
21. Swindle, E.J.; Hunt, J.A.; Coleman, J.W. A comparison of reactive oxygen species generation by rat peritoneal macrophages and mast cells using the highly sensitive real-time chemiluminescent probe pholasin: Inhibition of antigen-induced mast cell degranulation by macrophage-derived hydrogen peroxide. J. Immunol. 2002, 169, 5866–5873.
22. Kleijn, A.; Chen, J.W.; Buhrman, J.S.; Wojtkiewicz, G.R.; Iwamoto, Y.; Lamfers, M.L.; Stemmer-Rachamimov, A.O.; Rabkin, S.D.; Weissleder, R.; Martuza, R.L.; et al. Distinguishing inflammation from tumor and peritumoral edema by myeloperoxidase magnetic resonance imaging. Clin. Cancer Res. 2011, 17, 4484–4493.
23. Shepherd, J.; Hilderbrand, S.A.; Waterman, P.; Heinecke, J.W.; Weissleder, R.; Libby, P. A fluorescent probe for the detection of myeloperoxidase activity in atherosclerosis-associated macrophages. Chem. Biol. 2007, 14, 1221–1231.
24. Albers, A.E.; Dickinson, B.C.; Miller, E.W.; Chang, C.J. A red-emitting naphthofluorescein-based fluorescent probe for selective detection of hydrogen peroxide in living cells. Bioorg. Med. Chem. Lett. 2008, 18, 5948–5950.
25. Setsukinai, K.; Urano, Y.; Kakinuma, K.; Majima, H.J.; Nagano, T. Development of novel fluorescence probes that can reliably detect reactive oxygen species and distinguish specific species. J. Biol. Chem. 2003, 278, 3170–3175.
26. Kwon, J.; Kim, J.; Park, S.; Khang, G.; Kang, P.M.; Lee, D. Inflammation-responsive antioxidant nanoparticles based on a polymeric prodrug of vanillin. Biomacromolecules 2013, 14, 1618–1626.
27. Panizzi, P.; Nahrendorf, M.; Wildgruber, M.; Waterman, P.; Figueiredo, J.L.; Aikawa, E.; McCarthy, J.; Weissleder, R.; Hilderbrand, S.A. Oxazine conjugated nanoparticle detects in vivo hypochlorous acid and peroxynitrite generation. J. Am. Chem. Soc. 2009, 131, 15739–15744.
28. Huang, J.; Smith, F.; Panizzi, P. Ordered cleavage of myeloperoxidase ester bonds releases active site heme leading to inactivation of myeloperoxidase by benzoic acid hydrazide analogs. Arch. Biochem. Biophys. 2014, 548, 74–85.
29. Murray, P.J.; Wynn, T.A. Protective and pathogenic functions of macrophage subsets. Nat. Rev. Immunol. 2011, 11, 723–737.
30. Weissleder, R.; Nahrendorf, M.; Pittet, M.J. Imaging macrophages with nanoparticles. Nat. Mater. 2014, 13, 125–138.
31. Hitchens, T.K.; Ye, Q.; Eytan, D.F.; Janjic, J.M.; Ahrens, E.T.; Ho, C. 19F MRI detection of acute allograft rejection with in vivo perfluorocarbon labeling of immune cells. Magn. Reson. Med. 2011, 65, 1144–1153.
32. Majmudar, M.D.; Yoo, J.; Keliher, E.J.; Truelove, J.J.; Iwamoto, Y.; Sena, B.; Dutta, P.; Borodovsky, A.; Fitzgerald, K.; di Carli, M.F.; et al. Polymeric nanoparticle PET/MR imaging allows macrophage detection in atherosclerotic plaques. Circ. Res. 2013, 112, 755–761.
33. Nahrendorf, M.; Zhang, H.; Hembrador, S.; Panizzi, P.; Sosnovik, D.E.; Aikawa, E.; Libby, P.; Swirski, F.K.; Weissleder, R. Nanoparticle PET-CT imaging of macrophages in inflammatory atherosclerosis. Circulation 2008, 117, 379–387.
34. Lipinski, M.J.; Frias, J.C.; Amirbekian, V.; Briley-Saebo, K.C.; Mani, V.; Samber, D.; Abbate, A.; Aguinaldo, J.G.; Massey, D.; Fuster, V.; et al. Macrophage-specific lipid-based nanoparticles improve cardiac magnetic resonance detection and characterization of human atherosclerosis. JACC Cardiovasc. Imaging 2009, 2, 637–647.
35. Amirbekian, V.; Lipinski, M.J.; Briley-Saebo, K.C.; Amirbekian, S.; Aguinaldo, J.G.; Weinreb, D.B.; Vucic, E.; Frias, J.C.; Hyafil, F.; Mani, V.; et al. Detecting and assessing macrophages in vivo to evaluate atherosclerosis noninvasively using molecular MRI. Proc. Natl. Acad. Sci. USA 2007, 104, 961–966.
36. Bierry, G.; Jehl, F.; Boehm, N.; Robert, P.; Dietemann, J.L.; Kremer, S. Macrophage imaging by USPIO-enhanced MR for the differentiation of infectious osteomyelitis and aseptic vertebral inflammation. Eur. Radiol. 2009, 19, 1604–1611.
37. Rennen, H.J.; Frielink, C.; Brandt, E.; Zaat, S.A.; Boerman, O.C.; Oyen, W.J.; Corstens, F.H. Relationship between neutrophil-binding affinity and suitability for infection imaging: Comparison of (99m)Tc-labeled NAP-2 (CXCL-7) and 3 C-terminally truncated isoforms. J. Nucl. Med. 2004, 45, 1217–1223.
38. Bleeker-Rovers, C.P.; Rennen, H.J.; Boerman, O.C.; Wymenga, A.B.; Visser, E.P.; Bakker, J.H.; van der Meer, J.W.; Corstens, F.H.; Oyen, W.J. 99mTc-labeled interleukin 8 for the scintigraphic detection of infection and inflammation: First clinical evaluation. J. Nucl. Med. 2007, 48, 337–343.
39. Kipper, S.L.; Rypins, E.B.; Evans, D.G.; Thakur, M.L.; Smith, T.D.; Rhodes, B. Neutrophil-specific 99mTc-labeled anti-CD15 monoclonal antibody imaging for diagnosis of equivocal appendicitis. J. Nucl. Med. 2000, 41, 449–455.
40. Rennen, H.J.; Laverman, P.; van Eerd, J.E.; Oyen, W.J.; Corstens, F.H.; Boerman, O.C. PET imaging of infection with a HYNIC-conjugated LTB4 antagonist labeled with F-18 via hydrazone formation. Nucl. Med. Biol. 2007, 34, 691–695.
41. Albertine, K.H.; Gee, M.H. In vivo labeling of neutrophils using a fluorescent cell linker. J. Leukoc. Biol. 1996, 59, 631–638.
42. Locke, L.W.; Chordia, M.D.; Zhang, Y.; Kundu, B.; Kennedy, D.; Landseadel, J.; Xiao, L.; Fairchild, K.D.; Berr, S.S.; Linden, J.; et al. A novel neutrophil-specific PET imaging agent: CFLFLFK-PEG-64Cu. J. Nucl. Med. 2009, 50, 790–797.
43. Sugawara, Y.; Gutowski, T.D.; Fisher, S.J.; Brown, R.S.; Wahl, R.L. Uptake of positron emission tomography tracers in experimental bacterial infections: A comparative biodistribution study of radiolabeled FDG, thymidine, L-methionine, 67Ga-citrate, and 125I-HSA. Eur. J. Nucl. Med. 1999, 26, 333–341.
44. Tsan, M.F. Mechanism of gallium-67 accumulation in inflammatory lesions. J. Nucl. Med. 1985, 26, 88–92.
45. Wei, X.; Runnels, J.M.; Lin, C.P. Selective uptake of indocyanine green by reticulocytes in circulation. Investig. Ophthalmol. Vis. Sci. 2003, 44, 4489–4496.
46. Pham, W.; Xie, J.; Gore, J.C. Tracking the migration of dendritic cells by in vivo optical imaging. Neoplasia 2007, 9, 1130–1137.
47. Fan, Z.; Spencer, J.A.; Lu, Y.; Pitsillides, C.M.; Singh, G.; Kim, P.; Yun, S.H.; Toxavidis, V.; Strom, T.B.; Lin, C.P.; et al. In vivo tracking of ‘color-coded’ effector, natural and induced regulatory T cells in the allograft response. Nat. Med. 2010, 16, 718–722.
48. Progatzky, F.; Dallman, M.J.; Lo Celso, C. From seeing to believing: Labelling strategies for in vivo cell-tracking experiments. Interface Focus 2013, 3, 20130001, doi:10.1098/rsfs.2013.0001.
49. Ahrens, E.T.; Bulte, J.W. Tracking immune cells in vivo using magnetic resonance imaging. Nat. Rev. Immunol. 2013, 13, 755–763.
50. Srinivas, M.; Turner, M.S.; Janjic, J.M.; Morel, P.A.; Laidlaw, D.H.; Ahrens, E.T. In vivo cytometry of antigen-specific t cells using 19F MRI. Magn. Reson. Med. 2009, 62, 747–753.
51. de Vries, I.J.; Lesterhuis, W.J.; Barentsz, J.O.; Verdijk, P.; van Krieken, J.H.; Boerman, O.C.; Oyen, W.J.; Bonenkamp, J.J.; Boezeman, J.B.; Adema, G.J.; et al. Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. Nat. Biotechnol. 2005, 23, 1407–1413.
52. Arbab, A.S.; Frank, J.A. Cellular MRI and its role in stem cell therapy. Regen. Med. 2008, 3, 199–215.
53. Klionsky, D.J.; Abeliovich, H.; Agostinis, P.; Agrawal, D.K.; Aliev, G.; Askew, D.S.; Baba, M.; Baehrecke, E.H.; Bahr, B.A.; Ballabio, A.; et al. Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy 2008, 4, 151–175.
54. Liu, W.; Frank, J.A. Detection and quantification of magnetically labeled cells by cellular MRI. Eur. J. Radiol. 2009, 70, 258–264.
55. Annovazzi, A.; Biancone, L.; Caviglia, R.; Chianelli, M.; Capriotti, G.; Mather, S.J.; Caprilli, R.; Pallone, F.; Scopinaro, F.; Signore, A. 99mTc-interleukin-2 and (99m)Tc-HMPAO granulocyte scintigraphy in patients with inactive Crohn’s disease. Eur. J. Nucl. Med. Mol. Imaging 2003, 30, 374–382.
56. Annovazzi, A.; Bonanno, E.; Arca, M.; D’Alessandria, C.; Marcoccia, A.; Spagnoli, L.G.; Violi, F.; Scopinaro, F.; de Toma, G.; Signore, A. 99mTc-interleukin-2 scintigraphy for the in vivo imaging of vulnerable atherosclerotic plaques. Eur. J. Nucl. Med. Mol. Imaging 2006, 33, 117–126.
57. Di Gialleonardo, V.; Signore, A.; Glaudemans, A.W.; Dierckx, R.A.; de Vries, E.F. N-(4–18F-fluorobenzoyl)interleukin-2 for PET of human-activated T lymphocytes. J. Nucl. Med. 2012, 53, 679–686.
58. Signore, A.; Annovazzi, A.; Barone, R.; Bonanno, E.; D’Alessandria, C.; Chianelli, M.; Mather, S.J.; Bottoni, U.; Panetta, C.; Innocenzi, D.; et al. 99mTc-interleukin-2 scintigraphy as a potential tool for evaluating tumor-infiltrating lymphocytes in melanoma lesions: A validation study. J. Nucl. Med. 2004, 45, 1647–1652.
59. Signore, A.; Chianelli, M.; Annovazzi, A.; Bonanno, E.; Spagnoli, L.G.; Pozzilli, P.; Pallone, F.; Biancone, L. 123I-interleukin-2 scintigraphy for in vivo assessment of intestinal mononuclear cell infiltration in Crohn’s disease. J. Nucl. Med. 2000, 41, 242–249.
60. Signore, A.; Procaccini, E.; Annovazzi, A.; Chianelli, M.; van der Laken, C.; Mire-Sluis, A. The developing role of cytokines for imaging inflammation and infection. Cytokine 2000, 12, 1445–1454.
61. Tavare, R.; McCracken, M.N.; Zettlitz, K.A.; Knowles, S.M.; Salazar, F.B.; Olafsen, T.; Witte, O.N.; Wu, A.M. Engineered antibody fragments for immuno-PET imaging of endogenous CD8+ T cells in vivo. Proc. Natl. Acad. Sci. USA 2014, 111, 1108–1113.
62. Aoki, I.; Takahashi, Y.; Chuang, K.H.; Silva, A.C.; Igarashi, T.; Tanaka, C.; Childs, R.W.; Koretsky, A.P. Cell labeling for magnetic resonance imaging with the T1 agent manganese chloride. NMR Biomed. 2006, 19, 50–59.
63. Weissleder, R.; Gambhir, S.S. Molecular Imaging: Principles and Practice; People’s Medical Publishing House-USA: Shelton, CT, USA, 2010; p. 1326.
64. Goldenberg, D.M.; Chatal, J.F.; Barbet, J.; Boerman, O.; Sharkey, R.M. Cancer imaging and therapy with bispecific antibody pretargeting. Update Cancer Ther. 2007, 2, 19–31.
65. Thorek, D.L.; Tsao, P.Y.; Arora, V.; Zhou, L.; Eisenberg, R.A.; Tsourkas, A. In vivo, multimodal imaging of B cell distribution and response to antibody immunotherapy in mice. PLoS One 2010, 5, e10655.
66. Van Eerd, J.E.; Boerman, O.C.; Corstens, F.H.; Oyen, W.J. Radiolabeled chemotactic cytokines: New agents for scintigraphic imaging of infection and inflammation. Q. J. Nucl. Med. 2003, 47, 246–255.
67. Ohtsuki, K.; Hayase, M.; Akashi, K.; Kopiwoda, S.; Strauss, H.W. Detection of monocyte chemoattractant protein-1 receptor expression in experimental atherosclerotic lesions: An autoradiographic study. Circulation 2001, 104, 203–208.
68. Rucinski, B.; Knight, L.C.; Niewiarowski, S. Clearance of human platelet factor 4 by liver and kidney: Its alteration by heparin. Am. J. Physiol. 1986, 251, H800–H807.
69. Page-McCaw, A.; Ewald, A.J.; Werb, Z. Matrix metalloproteinases and the regulation of tissue remodelling. Nat. Rev. Mol. Cell Biol. 2007, 8, 221–233.
70. Hanaoka, H.; Mukai, T.; Habashita, S.; Asano, D.; Ogawa, K.; Kuroda, Y.; Akizawa, H.; Iida, Y.; Endo, K.; Saga, T.; et al. Chemical design of a radiolabeled gelatinase inhibitor peptide for the imaging of gelatinase activity in tumors. Nucl. Med. Biol. 2007, 34, 503–510.
71. Bremer, C.; Bredow, S.; Mahmood, U.; Weissleder, R.; Tung, C.H. Optical imaging of matrix metalloproteinase-2 activity in tumors: Feasibility study in a mouse model. Radiology 2001, 221, 523–529.
72. Scherer, R.L.; VanSaun, M.N.; McIntyre, J.O.; Matrisian, L.M. Optical imaging of matrix metalloproteinase-7 activity in vivo using a proteolytic nanobeacon. Mol. Imaging 2008, 7, 118–131.
73. Bremer, C.; Tung, C.H.; Weissleder, R. In vivo molecular target assessment of matrix metalloproteinase inhibition. Nat. Med. 2001, 7, 743–748.
74. Tung, C.H.; Mahmood, U.; Bredow, S.; Weissleder, R. In vivo imaging of proteolytic enzyme activity using a novel molecular reporter. Cancer Res. 2000, 60, 4953–4958.
75. Puri, A.W.; Broz, P.; Shen, A.; Monack, D.M.; Bogyo, M. Caspase-1 activity is required to bypass macrophage apoptosis upon Salmonella infection. Nat. Chem. Biol. 2012, 8, 745–747.
76. Mocarski, E.S.; Upton, J.W.; Kaiser, W.J. Viral infection and the evolution of caspase 8-regulated apoptotic and necrotic death pathways. Nat. Rev. Immunol. 2012, 12, 79–88.
77. Man, S.M.; Tourlomousis, P.; Hopkins, L.; Monie, T.P.; Fitzgerald, K.A.; Bryant, C.E. Salmonella infection induces recruitment of Caspase-8 to the inflammasome to modulate IL-1beta production. J. Immunol. 2013, 191, 5239–5246.
78. Chen, Y.; Zheng, W.; Li, Y.; Zhong, J.; Ji, J.; Shen, P. Apoptosis induced by methylene-blue-mediated photodynamic therapy in melanomas and the involvement of mitochondrial dysfunction revealed by proteomics. Cancer Sci. 2008, 99, 2019–2027.
79. Liu, T.; Wu, L.Y.; Choi, J.K.; Berkman, C.E. Targeted photodynamic therapy for prostate cancer: Inducing apoptosis via activation of the caspase-8/-3 cascade pathway. Int. J. Oncol. 2010, 36, 777–784.
80. Stefflova, K.; Chen, J.; Marotta, D.; Li, H.; Zheng, G. Photodynamic therapy agent with a built-in apoptosis sensor for evaluating its own therapeutic outcome in situ. J. Med. Chem. 2006, 49, 3850–3856.
81. Messerli, S.M.; Prabhakar, S.; Tang, Y.; Shah, K.; Cortes, M.L.; Murthy, V.; Weissleder, R.; Breakefield, X.O.; Tung, C.H. A novel method for imaging apoptosis using a caspase-1 near-infrared fluorescent probe. Neoplasia 2004, 6, 95–105.
82. Wyffels, L.; Gray, B.D.; Barber, C.; Moore, S.K.; Woolfenden, J.M.; Pak, K.Y.; Liu, Z. Synthesis and preliminary evaluation of radiolabeled bis(zinc(II)-dipicolylamine) coordination complexes as cell death imaging agents. Bioorg. Med. Chem. 2011, 19, 3425–3433.
83. Engeland, M.; van den Eijnde, S.M.; Aken, T.; Vermeij-Keers, C.; Ramaekers, F.C.; Schutte, B.; Reutelingsperger, C.P. Detection of apoptosis in ovarian cells in vitro and in vivo using the annexin V-affinity assay. Methods Mol. Med. 2001, 39, 669–677.
84. Ntziachristos, V.; Schellenberger, E.A.; Ripoll, J.; Yessayan, D.; Graves, E.; Bogdanov, A., Jr.; Josephson, L.; Weissleder, R. Visualization of antitumor treatment by means of fluorescence molecular tomography with an annexin V-Cy5.5 conjugate. Proc. Natl. Acad. Sci. USA 2004, 101, 12294–12299.
85. Leung, K. Annexin A5-quantum dot-DTPA-gadolinium. In Molecular Imaging and Contrast Agent Database (MICAD); National Center for Biotechnology Information (US): Bethesda, MD, USA, 2004.
86. D’Arceuil, H.; Rhine, W.; de Crespigny, A.; Yenari, M.; Tait, J.F.; Strauss, W.H.; Engelhorn, T.; Kastrup, A.; Moseley, M.; Blankenberg, F.G. 99mTc annexin V imaging of neonatal hypoxic brain injury. Stroke 2000, 31, 2692–2700.
87. Murakami, Y.; Takamatsu, H.; Taki, J.; Tatsumi, M.; Noda, A.; Ichise, R.; Tait, J.F.; Nishimura, S. 18F-labelled annexin V: A PET tracer for apoptosis imaging. Eur. J. Nucl. Med. Mol. Imaging 2004, 31, 469–474.
88. Bauer, C.; Bauder-Wuest, U.; Mier, W.; Haberkorn, U.; Eisenhut, M. 131I-labeled peptides as caspase substrates for apoptosis imaging. J. Nucl. Med. 2005, 46, 1066–1074.
89. Gahan, C.G. The bacterial lux reporter system: Applications in bacterial localisation studies. Curr. Gene Ther. 2012, 12, 12–19.
90. Hutchens, M.; Luker, G.D. Applications of bioluminescence imaging to the study of infectious diseases. Cell. Microbiol. 2007, 9, 2315–2322.
91. Sarda, L.; Saleh-Mghir, A.; Peker, C.; Meulemans, A.; Cremieux, A.C.; Le Guludec, D. Evaluation of (99m)Tc-ciprofloxacin scintigraphy in a rabbit model of Staphylococcus aureus prosthetic joint infection. J. Nucl. Med. 2002, 43, 239–245.
92. Siaens, R.H.; Rennen, H.J.; Boerman, O.C.; Dierckx, R.; Slegers, G. Synthesis and comparison of 99mTc-enrofloxacin and 99mTc-ciprofloxacin. J. Nucl. Med. 2004, 45, 2088–2094.
93. Nayak, D.K.; Baishya, R.; Halder, K.K.; Sen, T.; Sarkar, B.R.; Ganguly, S.; Das, M.K.; Debnath, M.C. Evaluation of (99m)Tc(i)-tricarbonyl complexes of fluoroquinolones for targeting bacterial infection. Metallomics 2012, 4, 1197–1208.
94. Britton, K.E.; Vinjamuri, S.; Hall, A.V.; Solanki, K.; Siraj, Q.H.; Bomanji, J.; Das, S. Clinical evaluation of technetium-99m infecton for the localisation of bacterial infection. Eur. J. Nucl. Med. 1997, 24, 553–556.
95. Britton, K.E.; Wareham, D.W.; Das, S.S.; Solanki, K.K.; Amaral, H.; Bhatnagar, A.; Katamihardja, A.H.; Malamitsi, J.; Moustafa, H.M.; Soroa, V.E.; et al. Imaging bacterial infection with (99m)Tc-ciprofloxacin (Infecton). J. Clin. Pathol. 2002, 55, 817–823.
96. Hall, A.V.; Solanki, K.K.; Vinjamuri, S.; Britton, K.E.; Das, S.S. Evaluation of the efficacy of 99mTc-Infecton, a novel agent for detecting sites of infection. J. Clin. Pathol. 1998, 51, 215–219.
97. Larikka, M.J.; Ahonen, A.K.; Niemela, O.; Puronto, O.; Junila, J.A.; Hamalainen, M.M.; Britton, K.; Syrjala, H.P. 99m Tc-ciprofloxacin (Infecton) imaging in the diagnosis of knee prosthesis infections. Nucl. Med. Commun. 2002, 23, 167–170.
98. Sarda, L.; Cremieux, A.C.; Lebellec, Y.; Meulemans, A.; Lebtahi, R.; Hayem, G.; Genin, R.; Delahaye, N.; Huten, D.; le Guludec, D. Inability of 99mTc-ciprofloxacin scintigraphy to discriminate between septic and sterile osteoarticular diseases. J. Nucl. Med. 2003, 44, 920–926.
99. Sonmezoglu, K.; Sonmezoglu, M.; Halac, M.; Akgun, I.; Turkmen, C.; Onsel, C.; Kanmaz, B.; Solanki, K.; Britton, K.E.; Uslu, I. Usefulness of 99mTc-ciprofloxacin (infecton) scan in diagnosis of chronic orthopedic infections: Comparative study with 99mTc-HMPAO leukocyte scintigraphy. J. Nucl. Med. 2001, 42, 567–574.
100. Vinjamuri, S.; Hall, A.V.; Solanki, K.K.; Bomanji, J.; Siraj, Q.; O’Shaughnessy, E.; Das, S.S.; Britton, K.E. Comparison of 99mTc infecton imaging with radiolabelled white-cell imaging in the evaluation of bacterial infection. Lancet 1996, 347, 233–235.
101. Issadore, D.; Min, C.; Liong, M.; Chung, J.; Weissleder, R.; Lee, H. Miniature magnetic resonance system for point-of-care diagnostics. Lab Chip 2011, 11, 2282–2287.
102. Lee, H.; Sun, E.; Ham, D.; Weissleder, R. Chip-NMR biosensor for detection and molecular analysis of cells. Nat. Med. 2008, 14, 869–874.
103. Lupetti, A.; Pauwels, E.K.; Nibbering, P.H.; Welling, M.M. 99mTc-antimicrobial peptides: Promising candidates for infection imaging. Q. J. Nucl. Med. 2003, 47, 238–245.
104. Nibbering, P.H.; Welling, M.M.; Paulusma-Annema, A.; Brouwer, C.P.; Lupetti, A.; Pauwels, E.K. 99mTc-Labeled UBI 29–41 peptide for monitoring the efficacy of antibacterial agents in mice infected with Staphylococcus aureus. J. Nucl. Med. 2004, 45, 321–326.
105. Welling, M.M.; Lupetti, A.; Balter, H.S.; Lanzzeri, S.; Souto, B.; Rey, A.M.; Savio, E.O.; Paulusma-Annema, A.; Pauwels, E.K.; Nibbering, P.H. 99mTc-labeled antimicrobial peptides for detection of bacterial and Candida albicans infections. J. Nucl. Med. 2001, 42, 788–794.
106. Welling, M.M.; Mongera, S.; Lupetti, A.; Balter, H.S.; Bonetto, V.; Mazzi, U.; Pauwels, E.K.; Nibbering, P.H. Radiochemical and biological characteristics of 99mTc-UBI 29–41 for imaging of bacterial infections. Nucl. Med. Biol. 2002, 29, 413–422.
107. Saeed, S.; Zafar, J.; Khan, B.; Akhtar, A.; Qurieshi, S.; Fatima, S.; Ahmad, N.; Irfanullah, J. Utility of (9)(9)mTc-labelled antimicrobial peptide ubiquicidin (29-41) in the diagnosis of diabetic foot infection. Eur. J. Nucl. Med. Mol. Imaging 2013, 40, 737–743.
108. Vallejo, E.; Martinez, I.; Tejero, A.; Hernandez, S.; Jimenez, L.; Bialostozky, D.; Sanchez, G.; Ilarraza, H.; Ferro-Flores, G. Clinical utility of 99mTc-labeled ubiquicidin 29-41 antimicrobial peptide for the scintigraphic detection of mediastinitis after cardiac surgery. Arch. Med. Res. 2008, 39, 768–774.
109. Rusckowski, M.; Gupta, S.; Liu, G.; Dou, S.; Hnatowich, D.J. Investigations of a (99m)Tc-labeled bacteriophage as a potential infection-specific imaging agent. J. Nucl. Med. 2004, 45, 1201–1208.
110. Rusckowski, M.; Gupta, S.; Liu, G.; Dou, S.; Hnatowich, D.J. Investigation of four (99m)Tc-labeled bacteriophages for infection-specific imaging. Nucl. Med. Biol. 2008, 35, 433–440.
111. Akhtar, M.S.; Imran, M.B.; Nadeem, M.A.; Shahid, A. Antimicrobial peptides as infection imaging agents: Better than radiolabeled antibiotics. Int. J. Pept. 2012, 2012, 965238, doi:10.1155/2012/965238.
112. Akhtar, M.S.; Iqbal, J.; Khan, M.A.; Irfanullah, J.; Jehangir, M.; Khan, B.; Ul-Haq, I.; Muhammad, G.; Nadeem, M.A.; Afzal, M.S.; et al. 99mTc-labeled antimicrobial peptide ubiquicidin (29–41) accumulates less in Escherichia coli infection than in Staphylococcus aureus infection. J. Nucl. Med. 2004, 45, 849–856.
113. Akhtar, M.S.; Khan, M.E.; Khan, B.; Irfanullah, J.; Afzal, M.S.; Khan, M.A.; Nadeem, M.A.; Jehangir, M.; Imran, M.B. An imaging analysis of (99m)Tc-UBI (29–41) uptake in S. aureus infected thighs of rabbits on ciprofloxacin treatment. Eur. J. Nucl. Med. Mol. Imaging 2008, 35, 1056–1064.
114. Akhtar, M.S.; Qaisar, A.; Irfanullah, J.; Iqbal, J.; Khan, B.; Jehangir, M.; Nadeem, M.A.; Khan, M.A.; Afzal, M.S.; Ul-Haq, I.; et al. Antimicrobial peptide 99mTc-ubiquicidin 29-41 as human infection-imaging agent: Clinical trial. J. Nucl. Med. 2005, 46, 567–573.
115. Bisognano, C.; Vaudaux, P.; Rohner, P.; Lew, D.P.; Hooper, D.C. Induction of fibronectin-binding proteins and increased adhesion of quinolone-resistant Staphylococcus aureus by subinhibitory levels of ciprofloxacin. Antimicrob. Agents Chemother. 2000, 44, 1428–1437.
116. Bredberg, A.; Brant, M.; Jaszyk, M. Ciprofloxacin-induced inhibition of topoisomerase II in human lymphoblastoid cells. Antimicrob. Agents Chemother. 1991, 35, 448–450.
117. Bryant, R.E.; Mazza, J.A. Effect of the abscess environment on the antimicrobial activity of ciprofloxacin. Am. J. Med. 1989, 87, 23S–27S.
118. Giraud, E.; Cloeckaert, A.; Kerboeuf, D.; Chaslus-Dancla, E. Evidence for active efflux as the primary mechanism of resistance to ciprofloxacin in Salmonella enterica serovar Typhimurium. Antimicrob. Agents Chemother. 2000, 44, 1223–1228.
119. Kang, S.L.; Rybak, M.J.; McGrath, B.J.; Kaatz, G.W.; Seo, S.M. Pharmacodynamics of levofloxacin, ofloxacin, and ciprofloxacin, alone and in combination with rifampin, against methicillin-susceptible and-resistant Staphylococcus aureus in an in vitro infection model. Antimicrob. Agents Chemother. 1994, 38, 2702–2709.
120. Li, D.; Renzoni, A.; Estoppey, T.; Bisognano, C.; Francois, P.; Kelley, W.L.; Lew, D.P.; Schrenzel, J.; Vaudaux, P. Induction of fibronectin adhesins in quinolone-resistant Staphylococcus aureus by subinhibitory levels of ciprofloxacin or by sigma B transcription factor activity is mediated by two separate pathways. Antimicrob. Agents Chemother. 2005, 49, 916–924.
121. Riesbeck, K.; Andersson, J.; Gullberg, M.; Forsgren, A. Fluorinated 4-quinolones induce hyperproduction of interleukin 2. Proc. Natl. Acad. Sci. USA 1989, 86, 2809–2813.
122. Kloepfer, J.A.; Mielke, R.E.; Nadeau, J.L. Uptake of CdSe and CdSe/ZnS quantum dots into bacteria via purine-dependent mechanisms. Appl. Environ. Microbiol. 2005, 71, 2548–2557.
123. Kloepfer, J.A.; Mielke, R.E.; Wong, M.S.; Nealson, K.H.; Stucky, G.; Nadeau, J.L. Quantum dots as strain-and metabolism-specific microbiological labels. Appl. Environ. Microbiol. 2003, 69, 4205–4213.
124. Kuru, E.; Hughes, H.V.; Brown, P.J.; Hall, E.; Tekkam, S.; Cava, F.; de Pedro, M.A.; Brun, Y.V.; VanNieuwenhze, M.S. In Situ probing of newly synthesized peptidoglycan in live bacteria with fluorescent D-amino acids. Angew. Chem. 2012, 51, 12519–12523.
125. Liu, X.; Cheng, D.; Gray, B.D.; Wang, Y.; Akalin, A.; Rusckowski, M.; Pak, K.Y.; Hnatowich, D.J. Radiolabeled Zn-DPA as a potential infection imaging agent. Nucl. Med. Biol. 2012, 39, 709–714.
126. White, A.G.; Fu, N.; Leevy, W.M.; Lee, J.J.; Blasco, M.A.; Smith, B.D. Optical imaging of bacterial infection in living mice using deep-red fluorescent squaraine rotaxane probes. Bioconjug. Chem. 2010, 21, 1297–1304.
127. White, A.G.; Gray, B.D.; Pak, K.Y.; Smith, B.D. Deep-red fluorescent imaging probe for bacteria. Bioorg. Med. Chem. Lett. 2012, 22, 2833–2836.
128. Lee, C.N.; Wang, Y.M.; Lai, W.F.; Chen, T.J.; Yu, M.C.; Fang, C.L.; Yu, F.L.; Tsai, Y.H.; Chang, W.H.; Zuo, C.S.; et al. Super-paramagnetic iron oxide nanoparticles for use in extrapulmonary tuberculosis diagnosis. Clin. Microbiol. Infect. 2012, 18, E149–E157.
129. Diaz, L.A., Jr.; Foss, C.A.; Thornton, K.; Nimmagadda, S.; Endres, C.J.; Uzuner, O.; Seyler, T.M.; Ulrich, S.D.; Conway, J.; Bettegowda, C.; et al. Imaging of musculoskeletal bacterial infections by [124I]FIAU-PET/CT. PLoS One 2007, 2, e1007.
130. Hernandez, F.J.; Huang, L.; Olson, M.E.; Powers, K.M.; Hernandez, L.I.; Meyerholz, D.K.; Thedens, D.R.; Behlke, M.A.; Horswill, A.R.; McNamara, J.O., II. Noninvasive imaging of Staphylococcus aureus infections with a nuclease-activated probe. Nat. Med. 2014, 20, 301–306.
131. Depke, M.; Surmann, K.; Hildebrandt, P.; Jehmlich, N.; Michalik, S.; Stanca, S.E.; Fritzsche, W.; Volker, U.; Schmidt, F. Labeling of the pathogenic bacterium Staphylococcus aureus with gold or ferric oxide-core nanoparticles highlights new capabilities for investigation of host-pathogen interactions. Cytom. Part A 2014, 85, 140–150.
132. Bayer, A.S.; Bolger, A.F.; Taubert, K.A.; Wilson, W.; Steckelberg, J.; Karchmer, A.W.; Levison, M.; Chambers, H.F.; Dajani, A.S.; Gewitz, M.H.; et al. Diagnosis and management of infective endocarditis and its complications. Circulation 1998, 98, 2936–2948.
133. Baddour, L.M.; Wilson, W.R.; Bayer, A.S.; Fowler, V.G., Jr.; Bolger, A.F.; Levison, M.E.; Ferrieri, P.; Gerber, M.A.; Tani, L.Y.; Gewitz, M.H.; et al. Infective endocarditis: Diagnosis, antimicrobial therapy, and management of complications: A statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: Endorsed by the Infectious Diseases Society of America. Circulation 2005, 111, e394–e434.
134. Li, J.S.; Sexton, D.J.; Mick, N.; Nettles, R.; Fowler, V.G., Jr.; Ryan, T.; Bashore, T.; Corey, G.R. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin. Infect. Dis. 2000, 30, 633–638.
135. Cabell, C.H.; Fowler, V.G., Jr. Repeated echocardiography after the diagnosis of endocarditis: Too much of a good thing? Heart 2004, 90, 975–976.
136. Chu, V.H.; Bayer, A.S. Use of echocardiography in the diagnosis and management of infective endocarditis. Curr. Infect. Dis. Rep. 2007, 9, 283–290.
137. Shapiro, S.M.; Bayer, A.S. Transesophageal and Doppler echocardiography in the diagnosis and management of infective endocarditis. Chest 1991, 100, 1125–1130.
138. Kouijzer, I.J.; Vos, F.J.; Janssen, M.J.; van Dijk, A.P.; Oyen, W.J.; Bleeker-Rovers, C.P. The value of 18F-FDG PET/CT in diagnosing infectious endocarditis. Eur. J. Nucl. Med. Mol. Imaging 2013, 40, 1102–1107.
139. Moghadam-Kia, S.; Nawaz, A.; Millar, B.C.; Moore, J.E.; Wiegers, S.E.; Torigian, D.A.; Basu, S.; Alavi, A. Imaging with (18)F-FDG-PET in infective endocarditis: Promising role in difficult diagnosis and treatment monitoring. Hell. J. Nucl. Med. 2009, 12, 165–167.
140. Vind, S.H.; Hess, S. Possible role of PET/CT in infective endocarditis. J. Nucl. Cardiol. 2010, 17, 516–519.
141. Yen, R.F.; Chen, Y.C.; Wu, Y.W.; Pan, M.H.; Chang, S.C. Using 18-fluoro-2-deoxyglucose positron emission tomography in detecting infectious endocarditis/endoarteritis: A preliminary report. Acad. Radiol. 2004, 11, 316–321.
142. Vilacosta, I.; Gomez, J. Complementary role of MRI in infectious endocarditis. Echocardiography 1995, 12, 673–676.
143. Riba, A.L.; Downs, J.; Thakur, M.L.; Gottschalk, A.; Andriole, V.T.; Zaret, B.L. Technetium-99m stannous pyrophosphate imaging of experimental infective endocarditis. Circulation 1978, 58, 111–119.
144. Riba, A.L.; Thakur, M.L.; Gottschalk, A.; Andriole, V.T.; Zaret, B.L. Imaging experimental infective endocarditis with indium-111-labeled blood cellular components. Circulation 1979, 59, 336–343.
145. Morguet, A.J.; Munz, D.L.; Ivancevic, V.; Werner, G.S.; Sandrock, D.; Bokemeier, M.; Kreuzer, H. Immunoscintigraphy using technetium-99m-labeled anti-NCA-95 antigranulocyte antibodies as an adjunct to echocardiography in subacute infective endocarditis. J. Am. Coll. Cardiol. 1994, 23, 1171–1178.
146. Erba, P.A.; Conti, U.; Lazzeri, E.; Sollini, M.; Doria, R.; de Tommasi, S.M.; Bandera, F.; Tascini, C.; Menichetti, F.; Dierckx, R.A.; et al. Added value of 99mTc-HMPAO-labeled leukocyte SPECT/CT in the characterization and management of patients with infectious endocarditis. J. Nucl. Med. 2012, 53, 1235–1243.
147. Rouzet, F.; Dominguez Hernandez, M.; Hervatin, F.; Sarda-Mantel, L.; Lefort, A.; Duval, X.; Louedec, L.; Fantin, B.; le Guludec, D.; Michel, J.B. Technetium 99m-labeled annexin V scintigraphy of platelet activation in vegetations of experimental endocarditis. Circulation 2008, 117, 781–789.
148. Leevy, W.M.; Gammon, S.T.; Jiang, H.; Johnson, J.R.; Maxwell, D.J.; Jackson, E.N.; Marquez, M.; Piwnica-Worms, D.; Smith, B.D. Optical imaging of bacterial infection in living mice using a fluorescent near-infrared molecular probe. J. Am. Chem. Soc. 2006, 128, 16476–16477.
149. Leevy, W.M.; Gammon, S.T.; Johnson, J.R.; Lampkins, A.J.; Jiang, H.; Marquez, M.; Piwnica-Worms, D.; Suckow, M.A.; Smith, B.D. Noninvasive optical imaging of Staphylococcus aureus bacterial infection in living mice using a Bis-dipicolylamine-Zinc(II) affinity group conjugated to a near-infrared fluorophore. Bioconjug. Chem. 2008, 19, 686–692.
150. Flacke, S.; Fischer, S.; Scott, M.J.; Fuhrhop, R.J.; Allen, J.S.; McLean, M.; Winter, P.; Sicard, G.A.; Gaffney, P.J.; Wickline, S.A.; et al. Novel MRI contrast agent for molecular imaging of fibrin: Implications for detecting vulnerable plaques. Circulation 2001, 104, 1280–1285.
151. Yokota, M.; Basi, D.L.; Herzberg, M.C.; Meyer, M.W. Anti-fibrin antibody binding in valvular vegetations and kidney lesions during experimental endocarditis. Microbiol. Immunol. 2001, 45, 699–707.
152. Hui, K.Y.; Haber, E.; Matsueda, G.R. Immunodetection of human fibrin using monoclonal antibody-64C5 in an extracorporeal chicken model. Thromb. Haemost. 1985, 54, 524–527.
153. Hui, K.Y.; Haber, E.; Matsueda, G.R. Monoclonal antibodies of predetermined specificity for fibrin: A rational approach to monoclonal antibody production. Hybridoma 1986, 5, 215–222.
154. Rosebrough, S.F.; Grossman, Z.D.; McAfee, J.G.; Kudryk, B.J.; Subramanian, G.; Ritter-Hrncirik, C.A.; Witanowski, L.S.; Tillapaugh-Fay, G.; Urrutia, E. Aged venous thrombi: Radioimmunoimaging with fibrin-specific monoclonal antibody. Radiology 1987, 162, 575–577.
155. Rosebrough, S.F.; Grossman, Z.D.; McAfee, J.G.; Kudryk, B.J.; Subramanian, G.; Ritter-Hrncirik, C.A.; Witanowski, L.S.; Tillapaugh-Fay, G.; Urrutia, E.; Zapf-Longo, C. Thrombus imaging with indium-111 and iodine-131-labeled fibrin-specific monoclonal antibody and its F(ab')2 and Fab fragments. J. Nucl. Med. 1988, 29, 1212–1222.
156. Rosebrough, S.F.; McAfee, J.G.; Grossman, Z.D.; Kudryk, B.J.; Ritter-Hrncirik, C.A.; Witanowski, L.S.; Maley, B.L.; Bertrand, E.A.; Gagne, G.M. Thrombus imaging: A comparison of radiolabeled GC4 and T2G1s fibrin-specific monoclonal antibodies. J. Nucl. Med. 1990, 31, 1048–1054.
157. Rosebrough, S.F.; McAfee, J.G.; Grossman, Z.D.; Schemancik, L.A. Immunoreactivity of 111In and 131I fibrin-specific monoclonal antibody used for thrombus imaging. J. Immunol. Methods 1989, 116, 123–129.
158. Alavi, A.; Gupta, N.; Palevsky, H.I.; Kelley, M.A.; Jatlow, A.D.; Byar, A.A.; Berger, H.J. Detection of thrombophlebitis with 111In-labeled anti-fibrin antibody: Preliminary results. Cancer Res. 1990, 50, 958s–961s.
159. Douketis, J.D.; Ginsberg, J.S.; Haley, S.; Julian, J.; Dwyer, M.; Levine, M.; Eisenberg, P.R.; Smart, R.; Tsui, W.; White, R.H.; et al. Accuracy and safety of (99m)Tc-labeled anti-D-dimer (DI-80B3) Fab' fragments (ThromboView(R)) in the diagnosis of deep vein thrombosis: A phase II study. Thromb. Res. 2012, 130, 381–389.
160. Morris, T.A.; Gerometta, M.; Yusen, R.D.; White, R.H.; Douketis, J.D.; Kaatz, S.; Smart, R.C.; Macfarlane, D.; Ginsberg, J.S. Detection of pulmonary emboli with 99mTc-labeled anti-D-dimer (DI-80B3)Fab' fragments (ThromboView). Am. J. Respir. Crit. Care Med. 2011, 184, 708–714.
161. Federspiel, J.J.; Stearns, S.C.; Peppercorn, A.F.; Chu, V.H.; Fowler, V.G., Jr. Increasing US rates of endocarditis with Staphylococcus aureus: 1999–2008. Arch. Intern. Med. 2012, 172, 363–365.
162. Fortes, C.Q.; Espanha, C.A.; Bustorff, F.P.; Zappa, B.C.; Ferreira, A.L.; Moreira, R.B.; Pereira, N.G.; Fowler, V.G., Jr.; Deshmukh, H. First reported case of infective endocarditis caused by community-acquired methicillin-resistant Staphylococcus aureus not associated with healthcare contact in Brazil. Braz. J. Infect. Dis. 2008, 12, 541–543.
163. Fowler, V.G., Jr.; Miro, J.M.; Hoen, B.; Cabell, C.H.; Abrutyn, E.; Rubinstein, E.; Corey, G.R.; Spelman, D.; Bradley, S.F.; Barsic, B.; et al. Staphylococcus aureus endocarditis: A consequence of medical progress. JAMA 2005, 293, 3012–3021.
164. Fowler, V.G., Jr.; Sanders, L.L.; Kong, L.K.; McClelland, R.S.; Gottlieb, G.S.; Li, J.; Ryan, T.; Sexton, D.J.; Roussakis, G.; Harrell, L.J.; et al. Infective endocarditis due to Staphylococcus aureus: 59 prospectively identified cases with follow-up. Clin. Infect. Dis. 1999, 28, 106–114.
165. Miro, J.M.; Anguera, I.; Cabell, C.H.; Chen, A.Y.; Stafford, J.A.; Corey, G.R.; Olaison, L.; Eykyn, S.; Hoen, B.; Abrutyn, E.; et al. Staphylococcus aureus native valve infective endocarditis: Report of 566 episodes from the International Collaboration on Endocarditis Merged Database. Clin. Infect. Dis. 2005, 41, 507–514.
166. Nienaber, J.J.; Sharma Kuinkel, B.K.; Clarke-Pearson, M.; Lamlertthon, S.; Park, L.; Rude, T.H.; Barriere, S.; Woods, C.W.; Chu, V.H.; Marin, M.; et al. Methicillin-susceptible Staphylococcus aureus endocarditis isolates are associated with clonal complex 30 genotype and a distinct repertoire of enterotoxins and adhesins. J. Infect. Dis. 2011, 204, 704–713.
167. Petti, C.A.; Fowler, V.G., Jr. Staphylococcus aureus bacteremia and endocarditis. Infect. Dis. Clin. N. Am. 2002, 16, 413–435, x–xi.
168. Rasmussen, R.V.; Host, U.; Arpi, M.; Hassager, C.; Johansen, H.K.; Korup, E.; Schonheyder, H.C.; Berning, J.; Gill, S.; Rosenvinge, F.S.; et al. Prevalence of infective endocarditis in patients with Staphylococcus aureus bacteraemia: The value of screening with echocardiography. Eur. J. Echocardiogr. 2011, 12, 414–420.
169. Petti, C.A.; Fowler, V.G., Jr. Staphylococcus aureus bacteremia and endocarditis. Infect. Dis. Clin. N. Am. 2002, 16, 413–435, x–xi.
170. Panizzi, P.; Nahrendorf, M.; Figueiredo, J.L.; Panizzi, J.R.; Marinelli, B.; Iwamoto, Y.; Keliher, E.; Maddur, A.A.; Waterman, P.; Kroh, H.K. et al. In Vitro detection of Staphylococcus aureus endocarditis by targeting pathogen-specific prothrombin activation. Nat. Med. 2011, 17, 1142–1146.
171. Friedrich, R.; Panizzi, P.; Fuentes-Prior, P.; Richter, K.; Verhamme, I.; Anderson, P.J.; Kawabata, S.; Huber, R.; Bode, W.; Bock, P.E. Staphylocoagulase is a prototype for the mechanism of cofactor-induced zymogen activation. Nature 2003, 425, 535–539.
172. Kroh, H.K.; Panizzi, P.; Bock, P.E. Von Willebrand factor-binding protein is a hysteretic conformational activator of prothrombin. Proc. Natl. Acad. Sci. USA 2009, 106, 7786–7791.
173. Panizzi, P.; Friedrich, R.; Fuentes-Prior, P.; Kroh, H.K.; Briggs, J.; Tans, G.; Bode, W.; Bock, P.E. Novel fluorescent prothrombin analogs as probes of staphylocoagulase–prothrombin interactions. J. Biol. Chem. 2006, 281, 1169–1178.
174. Van Oosten, M.; Schafer, T.; Gazendam, J.A.; Ohlsen, K.; Tsompanidou, E.; de Goffau, M.C.; Harmsen, H.J.; Crane, L.M.; Lim, E.; Francis, K.P.; et al. Real-time in vivo imaging of invasive-and biomaterial-associated bacterial infections using fluorescently labelled vancomycin. Nat. Commun. 2013, 4, 2584, doi:10.1038/ncomms3584.
175. Cremieux, A.C.; Vallois, J.M.; Maziere, B.; Ottaviani, M.; Bouvet, A.; Carbon, C.; Pocidalo, J.J. 3H-spiramycin penetration into fibrin vegetations in an experimental model of streptococcal endocarditis. J. Antimicrob. Chemother. 1988, 22 (Suppl. B), 127–133.
176. Pinkston, K.L.; Singh, K.V.; Gao, P.; Wilganowski, N.; Robinson, H.; Ghosh, S.; Azhdarinia, A.; Sevick-Muraca, E.M.; Murray, B.E.; Harvey, B.R. Targeting pili in enterococcal pathogenesis. Infect. Immun. 2014, 82, 1540–1547.